Search research articles
Contact Us
Filters
Showing results (171-180 of 460) with videos related to
Page
of 46
Sort By:
American Journal of Hematology
|
June 21, 2017
Early mortality in patients with acute myelogenous leukemia treated in teaching versus non-teaching hospitals: A large database analysis
Adam Levin, Ariel Kleman, Lisa Rein, et al.
JAMA Network Open
|
July 6, 2019
Factors Associated With Unplanned 30-Day Readmissions After Hematopoietic Cell Transplantation Among US Hospitals
Binod Dhakal, Smith Giri, Adam Levin, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 14, 2021
Budesonide Prophylaxis Reduces the Risk of Engraftment Syndrome After Autologous Hematopoietic Cell Transplantation in Multiple Myeloma
Binod Dhakal, Bicky Thapa, Huaying Dong, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 10, 2019
Efficacy, Toxicity, and Infectious Complications in Ruxolitinib-Treated Patients with Corticosteroid-Refractory Graft-versus-Host Disease after Hematopoietic Cell Transplantation
Sameem Abedin, Edward McKenna, Saurabh Chhabra, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 11, 2016
Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Impact of Disease Risk and Post Allograft Minimal Residual Disease on Survival
Binod Dhakal, Anita D'Souza, Michael Martens, et al.
Transplantation and Cellular Therapy
|
May 11, 2026
Impact of CD34+ Graft Cell Dose on Outcomes After Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis
Moazzam Shahzad, Muhammad Kashif Amin, Haritha Gandicheruvu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 28, 2020
Utilization and Cost Implications of Hematopoietic Progenitor Cells Stored for a Future Salvage Autologous Transplantation or Stem Cell Boost in Myeloma Patients
Saurabh Chhabra, Bicky Thapa, Aniko Szabo, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 23, 2024
The Glass Wall: Gendered Authorship Disparities in CD 19 and BCMA CAR-T Clinical Trials for Lymphoma and Myeloma
Aroog Khaliq, William Wesson, Emerson Logan, et al.
Future Oncology (London, England)
|
November 7, 2024
Understanding how CD19 expression levels impact the response to loncastuximab tesirine: a plain language summary
Paolo F Caimi, Mehdi Hamadani, Carmelo Carlo-Stella, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 8, 2018
Phase 1/2 Trial of Carfilzomib Plus High-Dose Melphalan Preparative Regimen for Salvage Autologous Hematopoietic Cell Transplantation Followed by Maintenance Carfilzomib in Patients with Relapsed/Refractory Multiple Myeloma
Luciano J Costa, Heather J Landau, Saurabh Chhabra, et al.
Page
of 46
Search research articles
Search
Showing results (171-180 of 460) with videos related to
Sort By:
Page
of 46
American Journal of Hematology
|
June 21, 2017
Early mortality in patients with acute myelogenous leukemia treated in teaching versus non-teaching hospitals: A large database analysis
Adam Levin, Ariel Kleman, Lisa Rein, et al.
JAMA Network Open
|
July 6, 2019
Factors Associated With Unplanned 30-Day Readmissions After Hematopoietic Cell Transplantation Among US Hospitals
Binod Dhakal, Smith Giri, Adam Levin, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 14, 2021
Budesonide Prophylaxis Reduces the Risk of Engraftment Syndrome After Autologous Hematopoietic Cell Transplantation in Multiple Myeloma
Binod Dhakal, Bicky Thapa, Huaying Dong, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 10, 2019
Efficacy, Toxicity, and Infectious Complications in Ruxolitinib-Treated Patients with Corticosteroid-Refractory Graft-versus-Host Disease after Hematopoietic Cell Transplantation
Sameem Abedin, Edward McKenna, Saurabh Chhabra, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 11, 2016
Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Impact of Disease Risk and Post Allograft Minimal Residual Disease on Survival
Binod Dhakal, Anita D'Souza, Michael Martens, et al.
Transplantation and Cellular Therapy
|
May 11, 2026
Impact of CD34+ Graft Cell Dose on Outcomes After Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis
Moazzam Shahzad, Muhammad Kashif Amin, Haritha Gandicheruvu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 28, 2020
Utilization and Cost Implications of Hematopoietic Progenitor Cells Stored for a Future Salvage Autologous Transplantation or Stem Cell Boost in Myeloma Patients
Saurabh Chhabra, Bicky Thapa, Aniko Szabo, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 23, 2024
The Glass Wall: Gendered Authorship Disparities in CD 19 and BCMA CAR-T Clinical Trials for Lymphoma and Myeloma
Aroog Khaliq, William Wesson, Emerson Logan, et al.
Future Oncology (London, England)
|
November 7, 2024
Understanding how CD19 expression levels impact the response to loncastuximab tesirine: a plain language summary
Paolo F Caimi, Mehdi Hamadani, Carmelo Carlo-Stella, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 8, 2018
Phase 1/2 Trial of Carfilzomib Plus High-Dose Melphalan Preparative Regimen for Salvage Autologous Hematopoietic Cell Transplantation Followed by Maintenance Carfilzomib in Patients with Relapsed/Refractory Multiple Myeloma
Luciano J Costa, Heather J Landau, Saurabh Chhabra, et al.
Page
of 46